Claar Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-51,200
Closed -$8.54M 35
2018
Q2
$8.54M Sell
51,200
-12,800
-20% -$2.05M 3.78% 12
2018
Q1
$10.8M Sell
64,000
-13,777
-18% -$2.31M 3.85% 14
2017
Q4
$12.7M Sell
77,777
-22,222
-22% -$3.99M 3.21% 13
2017
Q3
$20.5M Buy
99,999
+22,222
+29% +$5.17M 5.35% 4
2017
Q2
$18.9M Buy
77,777
+22,222
+40% +$5.22M 5.37% 6
2017
Q1
$13.3M Sell
55,555
-33,333
-38% -$7.76M 4.63% 8
2016
Q4
$18.7M Buy
+88,888
New +$18.4M 8.78% 3

Other funds holding AGN

Claar Advisors's AGN Position: Q3 2018 in Review

Claar Advisors sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 51,200 shares — an estimated $8.54M sold.

Claar Advisors first reported a position in AGN in Q4 2016 and held it in 7 quarters. The position peaked at $20.5M in Q3 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Claar Advisors reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Claar Advisors sold 51,200 Allergan plc shares in Q3 2018, an estimated $8.54M.
  • Claar Advisors first reported a position in Allergan plc in Q4 2016 and held it in 7 quarters.
  • Claar Advisors's Allergan plc position peaked at $20.5M in Q3 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Claar Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.